SOD1 and amyotrophic lateral sclerosis: Therefore, the data highlight the need to encourage extreme caution for individuals with ALS (and especially in the context of SOD1 mutation carriers) in the use of dietary supplements of long chain omega-3 fatty acids such as EPA.